Literature DB >> 3032326

Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension.

P C Waller, G T McInnes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032326      PMCID: PMC1245814          DOI: 10.1136/bmj.294.6574.769-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Initial dose of enalapril in hypertension.

Authors:  J Webster; D M Newnham; J C Petrie
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-01

2.  Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension.

Authors:  G A MacGregor; N D Markandu; F E Best; D M Elder; J M Cam; G A Sagnella; M Squires
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

3.  Does angiotensin-II protect against strokes?

Authors:  M J Brown; J Brown
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.